Afghanistan joins Madrid System for international trademark registrations

The number of countries and regions joining the international system for trademark registration on the basis of the Madrid Convention and its Protocol, continues to grow. Afghanistan is the latest country to deposit an instrument of accession with the World Intellectual Property Organization (WIPO), which comes into force on 26 June 2018.

The international system for trademark registration (also known as the Madrid System) makes it possible to request trademark protection in one or more member states of the Madrid System by filing one application at WIPO in Geneva, Switzerland.

The Madrid System dates back to the ‘Madrid Agreement’ of 1891 and has been expanded with the ‘Madrid Protocol' in 1996. Since the accession of Algeria to the Protocol in October 2015, all international trademark registrations are exclusively governed by the Madrid Protocol, making the Madrid Agreement essentially a non-operational treaty.

Afghanistan is the 101st member of the Madrid System. After Afghanistan’s accession the Madrid System will cover 117 countries in total, including the EU member states and the three countries of the Benelux.

That more and more countries and regions can be designated in an international trademark registration makes it increasingly appealing for businesses to apply for an international registration. For an analysis of the pros and cons of the Madrid System, read this article.

When the outlet of your business focuses on several countries or when it is about to enter new markets, it is important to determine whether your interests are sufficiently protected in those countries and regions. For advice on the international registration and further information on trademark protection in Afghanistan, please contact your Novagraaf consultant.

Frouke Hekker works at Novagraaf’s Competence Centre. She is based in Amsterdam.

Insights liés

Articles

Oncologie : l'Europe excelle en stratups mais peine à s'imposer dans l'innovation de pointe

L'Office européen des brevets (OEB) a publié le mois dernier sa deuxième étude en matière d’innovation dans les technologies anticancéreuses. Selon cette étude, l'Europe est en tête en nombre de startups dédiées à l'oncologie mais recule face aux États-Unis et à la Chine dans les domaines technologiques les plus innovants contre le cancer, notamment en immunothérapie cellulaire, thérapie génique et analyse d’images. Par ailleurs, la recherche publique joue un rôle central dans l’innovation oncologique européenne, la France se distinguant particulièrement avec l’INSERM et le CNRS, classés deuxième et troisième mondialement pour les dépôts de brevets liés au cancer.

Par Nadège Lagneau,
Oncologie : l'Europe excelle en stratups mais peine à s'imposer dans l'innovation de pointe

Pour plus d'informations ou de conseils contactez-nous